Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management.

Literature DB >> 32617120

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management.

Mahmoud Abdelnabi¹, Nouran Eshak^2,3, Yehia Saleh^4,5, Abdallah Almaghraby⁴.

Abstract

The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respiratory symptoms, several reports have noted myocarditis, cardiomyopathy, arrhythmias and cardiac arrests as COVID-19 complications. Here, the authors highlight the current understanding of the pathophysiology of myocarditis related to COVID-19 and its management.

Entities: Chemical Disease Gene Species

Keywords: COVID-19; cytokine storm; immunomodulation; myocarditis

Year: 2020 PMID： 32617120 PMCID： PMC7325211 DOI： 10.15420/ecr.2020.16

Source DB: PubMed Journal: Eur Cardiol ISSN： 1758-3756

10 in total

1. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors: Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal: Eur Heart J Date: 2013-07-03 Impact factor: 29.983

Review 2. Corticosteroids for viral myocarditis.

Authors: Huai Sheng Chen; Wei Wang; Sheng Nan Wu; Jian Ping Liu
Journal: Cochrane Database Syst Rev Date: 2013-10-18

3. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Authors: Riccardo M Inciardi; Laura Lupi; Gregorio Zaccone; Leonardo Italia; Michela Raffo; Daniela Tomasoni; Dario S Cani; Manuel Cerini; Davide Farina; Emanuele Gavazzi; Roberto Maroldi; Marianna Adamo; Enrico Ammirati; Gianfranco Sinagra; Carlo M Lombardi; Marco Metra
Journal: JAMA Cardiol Date: 2020-07-01 Impact factor: 14.676

Review 4. A systematic review of intravenous gamma globulin for therapy of acute myocarditis.

Authors: Joan L Robinson; Lisa Hartling; Ellen Crumley; Ben Vandermeer; Terry P Klassen
Journal: BMC Cardiovasc Disord Date: 2005-06-02 Impact factor: 2.298

5. COVID-19 and the cardiovascular system.

Authors: Ying-Ying Zheng; Yi-Tong Ma; Jin-Ying Zhang; Xiang Xie
Journal: Nat Rev Cardiol Date: 2020-05 Impact factor: 32.419

6. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Authors: Jia-Hui Zeng; Ying-Xia Liu; Jing Yuan; Fu-Xiang Wang; Wei-Bo Wu; Jin-Xiu Li; Li-Fei Wang; Hong Gao; Yao Wang; Chang-Feng Dong; Yi-Jun Li; Xiao-Juan Xie; Cheng Feng; Lei Liu
Journal: Infection Date: 2020-04-10 Impact factor: 3.553

Review 7. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management.

Authors: Bhurint Siripanthong; Saman Nazarian; Daniele Muser; Rajat Deo; Pasquale Santangeli; Mohammed Y Khanji; Leslie T Cooper; C Anwar A Chahal
Journal: Heart Rhythm Date: 2020-05-05 Impact factor: 6.343

8. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

Authors: Qiurong Ruan; Kun Yang; Wenxia Wang; Lingyu Jiang; Jianxin Song
Journal: Intensive Care Med Date: 2020-03-03 Impact factor: 17.440

9. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.

Authors: Hongde Hu; Fenglian Ma; Xin Wei; Yuan Fang
Journal: Eur Heart J Date: 2021-01-07 Impact factor: 29.983

10. SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

Authors: Chen Chen; Yiwu Zhou; Dao Wen Wang
Journal: Herz Date: 2020-05 Impact factor: 1.740

10 in total

6 in total

Coronavirus Disease 2019 Myocarditis: Insights into Pathophysiology and Management.

1. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Review 2. Corticosteroids for viral myocarditis.

3. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).

Review 4. A systematic review of intravenous gamma globulin for therapy of acute myocarditis.

5. COVID-19 and the cardiovascular system.

6. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Review 7. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management.

8. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.

9. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.

10. SARS-CoV-2: a potential novel etiology of fulminant myocarditis.

1. Cardiovascular impact of COVID-19 with a focus on children: A systematic review.

2. Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.

Review 3. COVID-19 and myocarditis: a review of literature.

4. A Young Lady With Myopericarditis: An Unusual Presentation of COVID-19 Infection.

5. "Heart failure in COVID-19 patients: Critical care experience": A letter to the editor.

6. ST-Elevation Myocardial Infarction as a Late Complication of Mild Coronavirus Disease 2019 Infection: A Case Report.